Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
ExaWizards Inc. ( (JP:4259) ) just unveiled an update.
ExaWizards Inc. has announced the commercialization of a new AI-powered medical application, LocoStep, developed by its subsidiary ExaMD Inc. LocoStep is designed to measure motor function using a smartphone or iPad, addressing the growing issue of impaired motor function among Japan’s aging population. While the immediate financial impact is expected to be minimal, the application represents a significant step in leveraging AI to tackle health challenges in a super-aging society.
More about ExaWizards Inc.
ExaWizards Inc. operates in the AI technology industry, focusing on developing solutions that address social issues related to health and medical themes, such as dementia. Their subsidiary, ExaMD Inc., specializes in planning, development, and sales of products utilizing multimodal AI technology, particularly in the medical field.
Average Trading Volume: 1,583,009
Technical Sentiment Signal: Buy
Current Market Cap: Yen36.28B
See more data about 4259 stock on TipRanks’ Stock Analysis page.